{'fraction_non_alphanumeric': 0.03742331288343558, 'fraction_numerical': 0.04049079754601227, 'mean_word_length': 4.682926829268292, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
PROGNOSTIC VALUE OF BIOCHEMICAL MARKERS IN PURULENT-CEPTIC COMPLICATIONS OF ACUTE SEVERE PANCREATITIS

One of the most pressing issues of urgent abdominal surgery is acute pancreatitis. The incidence of pancreatitis increases annually by 2.5 - 3.1%, ranging from 15 to 70 cases per 100,000 population in Europe and North America. About 40% of patients die within the first 7 days after hospitalization, most in the first 3 days. Patients with acute severe pancreatitis who are experiencing the first wave of the disease have a high risk of secondary infection of the pancreatic necrosis foci that is an indication for surgical intervention. This article presents the analysis of the  treatment results in 22 patients with acute severe pancreatitis, 7 (31.8%) men and 15 (68.2%) women. Age of patients ranged from 22 to 79 years (46,9 ± 1,5 years). 2-7 days was the time from the onset of the disease to hospital admission. Purulent-septic complications developed in 22 (100.0%) patients, the presence of sequestrate was detected in 9 of them (40.9%). The average period of hospital staying for this group of patients was 48.3 ± 4.4 days; the mortality rate was 27.3% (6 patients). Having analyzing the biochemical markers obtained, we can state that the increase in the level of procalcitonin and C-reactive protein indicates the development of purulent-septic complications in patients with acute severe pancreatitis, while the decrease in the free T3 concentration at normal T4 and TSH levels in 6 (27.3%) of patients, suggests the development of their lowT3 syndrome that in turn suggests an unfavourable course of the disease.